|
Markt geschlossen -
Euronext Bruxelles
17:55:00 26.10.2026
|
Perf. 5 T | Veränd. 1. Jan. | ||
| 270.30 EUR | -0.88% |
|
+31.73% | +13.29% |
| 26.10. | UCB: Weniger versprechen, mehr liefern - ganz nach UCB-Art |  |
| 26.10. | BofA hebt Kursziel und EPS-Prognosen für UCB nach "überraschender" Anhebung der FY26-Prognose an | MT |
ETFs investiert in UCB
| Name | % 1. Jan. | Gewichtung | Volumen | |
|---|---|---|---|---|
 | +7.42% | - | 6 576 M€ | |
| +16.28% | - | 750 M€ | |
| +11.40% | - | 13 M€ | |
| +0.72% | - | 51 M€ | |
| +11.52% | - | 66 M€ | |
| +9.96% | - | 75 M€ | |
| +14.55% | - | 4 105 M€ | |
| +7.51% | - | 274 M€ | |
| +5.94% | - | 298 M€ | |
| +7.03% | - | 6 M€ | |
| -.--% | - | 1 683 M€ | |
| +12.50% | - | 1 674 M€ | |
| +5.03% | - | 1 193 M€ | |
| +15.17% | 13.82% | 85 M€ | |
| +6.86% | 9% | 162 M€ | |
| +17.33% | 4.37% | 49 M€ | |
| +7.66% | 4.19% | 94 M€ | |
| +7.13% | 2.41% | 391 M€ | |
| +24.12% | 2.2% | 1 260 M€ | |
| +7.11% | 1.85% | 1 024 M€ | |
| +10.11% | 1.85% | 9 M€ | |
| +3.25% | 1.79% | 25 M€ | |
| +4.83% | 1.75% | 820 M€ | |
| +8.58% | 1.69% | 31 M€ | |
| +16.87% | 1.69% | 31 M€ | |
| +12.17% | 1.49% | 18 M€ | |
| +6.98% | 1.45% | 490 M€ | |
| +6.61% | 1.45% | 3 283 M€ | |
| +10.90% | 1.34% | 160 M€ | |
| +9.74% | 1.3% | 64 M€ | |
| +15.04% | 1.28% | 173 M€ | |
| +9.74% | 1.19% | 757 M€ | |
| +13.16% | 1.18% | 17 M€ | |
| +16.56% | 1.17% | 13 M€ | |
| +9.51% | 1.13% | 22 M€ | |
| +11.66% | 1.13% | 16 M€ |
Beschäftigte
9’000
Sektor
Pharmazeutika
Termine
- Börse
- Aktien
- 852738 Aktie
- ETFs UCB
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
